Neurent Medical, the pioneer behind Neuromark, a minimally invasive solution to treat chronic rhinitis, has closed its oversubscribed Series C financing, raising €62.5m (US$74m) to drive commercial expansion, broaden clinical…
Ireland: Neurent Medical raises €62.5m in oversubscribed Series C to accelerate Neuromark commercial expansion
…
…






